2Eyes Vision
2Eyes Vision develops and commercializes the SimVis Gekko, a binocular see-through visual simulator that enables ophthalmologists and cataract surgeons to let patients preview their postoperative vision with different intraocular lens options before surgery.
- Company typePrivate
- Founded2015
- HeadquartersMadrid, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What 2Eyes Vision does
2Eyes Vision (legal entity: 2 Eyes Vision, S.L.) is a Madrid-based medical device company founded in 2015 as a spin-off from the Visual Optics and Biophotonics Lab (VioBio Lab) of the Spanish National Research Council (CSIC). The company develops and commercializes the SimVis Gekko, a binocular, see-through, head-mounted visual simulator that uses optoelectronic tunable lenses to replicate multifocal intraocular lens (IOL) corrections in real time, allowing cataract and presbyopia patients to "test-drive" their postoperative vision (monofocal, enhanced monofocal, EDOF, bifocal, trifocal, and mix-and-match combinations) prior to surgery. The technology is backed by a global exclusive license from CSIC, 20+ patent families, and 25+ peer-reviewed publications resulting from more than a decade of joint R&D between the founders and the lab. Co-founders include CEO Carlos Dorronsoro, Prof. Susana Marcos (Director of the Center for Visual Science at the University of Rochester and former Director of CSIC's Institute of Optics), and mechanical engineer José Ramón Alonso Sanz.
The company's commercial portfolio includes the original SimVis Gekko, the next-generation SimVis Gekko2 (launched June 2025), and SimVis Academy, an e-learning and clinician certification platform launched in April 2026. Revenue is generated primarily through enterprise hardware sales to ophthalmology clinics and hospitals, supplemented by channel/distributor revenue (notably an exclusive distribution agreement with Guangzhou DMK Technology for Greater China) and recurring professional services/training revenue from SimVis Academy. Pricing is quote-based with no public tiers disclosed. The go-to-market motion combines direct enterprise sales with live demonstrations at major ophthalmology congresses (ESCRS, FacoElche, BRASCRS, SEO, AECOS, ISOP), industry collaborations with premium IOL manufacturers such as Alcon, and dedicated geographic partners (DMK in China, Strategic Operating Partner Nivine Woods for the United States).
The company serves two primary customer segments: ophthalmology clinics, eye surgeons, and refractive specialists who need preoperative IOL counseling tools (addressing up to 27% post-operative dissatisfaction driven by expectation-reality gaps), and the end-patients (cataract and presbyopia candidates) who benefit from personalized visual simulation before irreversible surgical decisions. Headcount is in the 11–50 range per firmographic data, and the company has raised approximately $6.6M+ in disclosed funding across multiple rounds led by Bullnet Capital with co-investment from CDTI Innvierte, plus grants from EIT Health and Luminate NY. The company holds ISO 9001:2015 certification, official Innovative SME status from the Spanish Ministry of Science, Innovation and Universities, and has been recognized through awards including the Edwin H. Land Medal and the Edgar D. Tillyer Award to its scientific co-founder.
2Eyes Vision firmographics
Firmographics- Name
- 2Eyes Vision
- Legal name
- 2 Eyes Vision, S.L.
- Website
- https://2eyesvision.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- 2Eyes Vision develops and commercializes the SimVis Gekko, a binocular see-through visual simulator that enables ophthalmologists and cataract surgeons to let patients preview their postoperative vision with different intraocular lens options before surgery.
- Ownership category
- akta.pro rank
2Eyes Vision industry classification
Industry- Product category
- Ophthalmic Visual Simulation Devices
- NAICS
- Ophthalmic Goods Manufacturing (339115)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)
- akta.pro secondary industry
- Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)
Keywords
Where 2Eyes Vision is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
2Eyes Vision business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Revenue model
- Hardware device sales (SimVis Gekko): Sale of the SimVis Gekko binocular visual simulator hardware to ophthalmology clinics, hospitals, and eye care practices for preoperative IOL counseling.
- Channel/distributor revenue: Revenue generated through exclusive distribution partnerships such as the agreement with Guangzhou DMK Technology Co., Ltd. for Greater China market.
- Professional services / training: SimVis Academy e-learning platform providing clinical training and certification for clinicians integrating SimVis Gekko into preoperative workflows. Platform includes educational modules, webinars, and personalized tutorials.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | No public pricing available |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels11 records
2Eyes Vision product offering
Product offeringCore offering
2Eyes Vision develops and commercializes SimVis Gekko, a binocular, see-through, head-mounted visual simulator that uses optoelectronic tunable lenses to simulate monofocal, trifocal, EDOF and mix-and-match intraocular lens (IOL) corrections in real-time, enabling presbyopia and cataract patients to preview their postoperative vision before surgery. The offering is sold to ophthalmology clinics, hospitals and refractive surgery centers, and is complemented by the SimVis Gekko2 next-generation device and the SimVis Academy clinical training platform.
Product overview
2EyesVision is a technology company specializing in ophthalmic visual simulation. The core product portfolio consists of SimVis Gekko and SimVis Gekko2, binocular visual simulators that enable patients to preview their vision with different intraocular lenses before surgery. Supporting the core devices is SimVis Academy, an e-learning platform for clinical training and certification. The company also licenses the SimVis technology (patented by CSIC) globally. All products work together to enable personalized presbyopia and cataract treatment decisions.
Differentiator
Problem solved
Functional benefit
Brands
- SimVis Gekko: The world's first binocular, see-through visual simulator enabling patients to experience real-world vision through different presbyopic corrections (IOLs, contact lenses, LASIK patterns) before surgery.
- SimVis Academy
Products and services
- SimVis Gekko A binocular, see-through, head-mounted visual simulator that uses optoelectronic tunable lenses to simulate monofocal, trifocal, EDOF, and mix-and-match intraocular lens (IOL) corrections in real-time, enabling presbyopia and cataract patients to preview their postoperative vision before surgery. Sold to ophthalmology clinics, hospitals, and refractive surgery centers for preoperative IOL counseling.
- SimVis Gekko2 Next-generation release of the SimVis Gekko binocular visual simulator, offering enhanced real-time, real-world IOL simulation capabilities for preoperative planning in cataract and presbyopia surgery. Sold to ophthalmology clinics and hospitals.
- SimVis Academy An e-learning platform providing structured clinical training, certification, educational modules, scientific content, and webinars for clinicians integrating SimVis Gekko into preoperative IOL counseling workflows. Available in English with additional languages under development.
Quantifiable outcome
- Up to 27% of patients report dissatisfaction after cataract surgery even with clinically excellent outcomes due to expectation-reality gap that SimVis Gekko addresses
- +2 more outcomes
Companies that use 2Eyes Vision
Customer profileNamed customers8 records
Segments2 records
Ideal customer profiles3 records
2Eyes Vision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
2Eyes Vision partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Guangzhou DMK Technology Co., Ltd.coreExclusive distribution agreement for Mainland China, Hong Kong, and Macao. DMK Technology, founded in 1997, specializes in ophthalmic technologies and has extensive experience introducing innovative international solutions into the Chinese market. This partnership represents a significant commercial milestone for 2EyesVision's international expansion in one of the world's largest ophthalmology markets. Signed by Máximo Gómez, Chief Strategy Officer at 2EyesVision, and Marica D'Angelo, International Markets Manager at DMK.
- FENIN (Spanish Federation of Healthcare Technology Companies)core2EyesVision joined FENIN, the main organization representing the MedTech industry in Spain. Membership reinforces the company's institutional presence, enables contribution to sector advancement, and opens opportunities for partnerships, knowledge exchange, and market expansion. For investors, it signals maturity and integration within Spain's key strategic MedTech ecosystem. CEO Carlos Dorronsoro stated: 'Joining FENIN is an opportunity to help shape the future of healthcare technology in Spain from within the ecosystem.'
- Nivine Woods (Strategic Operating Partner)coreNivine Woods, with more than 20 years of experience in eye care including senior leadership roles at Alcon, Abbott, Johnson & Johnson, and most recently CMO at EyeCare Partners (one of the largest PE-backed ophthalmology networks in the U.S.), has been engaged as Strategic Operating Partner to guide U.S. market development and engagement with leading ophthalmologists. She previously served as President of Ophthalmic World Leaders (OWL). Her experience across ophthalmology, optometry, and retina supports 2EyesVision's strategy to expand SimVis Gekko adoption in the United States.
- AlconcoreIndustry collaboration at ESCRS 2025 where Alcon showcased its multifocal IOL portfolio through SimVis Gekko at its booth. Visitors experienced firsthand how patients can preview their postoperative vision with Alcon lenses before surgery. This partnership reflects the growing trust of the industry in visual simulation as a clinical and commercial differentiator, and positions SimVis Gekko within Alcon's premium IOL ecosystem.
- CSIC (Spanish National Research Council) / Visual Optics and Biophotonics Labcore2EyesVision is a spin-off of CSIC's Visual Optics and Biophotonics Lab (VioBio Lab). The company holds a global exclusive license to the SimVis Technology developed at the lab. More than 10 years of joint research and development with 25+ scientific articles published. Prof. Susana Marcos, former Director of CSIC's Institute of Optics, is co-founder. Joint FacoElche + CSIC + 2EyesVision Research Grant awarded to Vissum Miranza Alicante and Hospital San Rafael Madrid for halo measurement studies.
Scale indicators10 records
Recent moves7 records
Expansion highlights7 records
2Eyes Vision competitors and assessment
Company assessmentBroad incumbents
- Alcon: Global leader in ophthalmic devices and premium IOLs (PanOptix, Vivity). Already showcased SimVis Gekko at ESCRS 2025, illustrating both the commercial overlap and the risk that a dominant IOL manufacturer could develop or bundle competing visual simulation.
- Heidelberg Engineering: Specialist in ophthalmic diagnostic imaging (OCT, confocal microscopy, perimetry). Comparable as a medtech vendor selling diagnostic/preoperative equipment into the same ophthalmology clinic call point.
- Haag-Streit: Swiss manufacturer of ophthalmic diagnostic devices and imaging (slit lamps, perimeters, OCT) sold into the same clinical specialty channel. Relevant as an adjacent diagnostic/preoperative equipment vendor to the same ophthalmologist buyer.
- Bausch + Lomb: Diversified ophthalmic company with premium IOLs (enVista, Trulign) and surgical instruments. Comparable as a potential distribution/clinical partner or competitor in the premium IOL counseling workflow.
- Johnson & Johnson Vision: Major IOL manufacturer (TECNIS multifocal/EDOF family) with extensive clinical relationships. Relevant as both a potential channel partner for SimVis Gekko and a potential competitor that could internalize visual simulation within its premium IOL workflow.
- Topcon Healthcare: Major ophthalmic instrument and imaging company with devices sold into the same optometry/ophthalmology clinic channel. Comparable on go-to-market and customer overlap even though product categories differ.
- Carl Zeiss Meditec: Broad ophthalmic diagnostics and surgical microscope portfolio with established surgeon relationships. Comparable as a medtech incumbent that could integrate preoperative simulation into its existing cataract surgery ecosystem.
Emerging players
- Plenoptika: Spin-off of Prof. Susana Marcos's VioBio Lab (same founder as 2EyesVision) that commercializes QuickSee, a handheld autorefractor. Comparable as a fellow CSIC visual-optics spin-out translating academic research into ophthalmic hardware, though it addresses refractive measurement rather than IOL simulation.
Direct peers
- VRmagic (Eyesi): Provider of Eyesi surgical and diagnostic simulators for ophthalmology training (cataract, vitreoretinal). Closest direct functional analog: visual/surgical simulation hardware used in ophthalmology, though focused on training rather than patient preoperative IOL counseling.
- iVis Technologies: Italian company offering ray-tracing-based IOL calculation and custom refractive surgery planning (iTrace, SuPrima). Comparable as a high-tech preoperative planning tool for cataract/refractive surgeons, addressing a similar clinical decision point with simulation technology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
2Eyes Vision social profiles
Digital presence2Eyes Vision compliance and trust
Trust signalCompliance2 records
2Eyes Vision financial estimates
Financial estimateRevenue estimate
Valuation estimate
2Eyes Vision leadership team
Management profileNumber of profiles
Profiles7 records
2Eyes Vision funding detail
Funding detailFunding overview
Funding rounds12 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
2Eyes Vision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 2Eyes Vision
What does 2Eyes Vision do?
2Eyes Vision develops and commercializes SimVis Gekko, a binocular, see-through, head-mounted visual simulator that uses optoelectronic tunable lenses to simulate monofocal, trifocal, EDOF and mix-and-match intraocular lens (IOL) corrections in real-time, enabling presbyopia and cataract patients to preview their postoperative vision before surgery. The offering is sold to ophthalmology clinics, hospitals and refractive surgery centers, and is complemented by the SimVis Gekko2 next-generation device and the SimVis Academy clinical training platform.
Is 2Eyes Vision a public or private company?
2Eyes Vision is a private company. It is classified as venture growth investor backed and is currently operating.
When was 2Eyes Vision founded?
2Eyes Vision was founded in 2015. It employs 11 to 50 people.
Where is 2Eyes Vision based?
2Eyes Vision is headquartered in Madrid, Spain, in the Europe region.
How does 2Eyes Vision make money?
Three revenue lines are on record. Hardware device sales (SimVis Gekko) is the primary driver. The others are channel/distributor revenue and professional services / training.
Who are 2Eyes Vision's main competitors?
Broad incumbents on record are Alcon, Heidelberg Engineering, Haag-Streit, Bausch + Lomb, Johnson & Johnson Vision, Topcon Healthcare and Carl Zeiss Meditec. Plenoptika is listed as an emerging player. Direct peers are VRmagic (Eyesi) and iVis Technologies.
Does 2Eyes Vision have an API?
No public API is recorded for 2Eyes Vision.
What industry is 2Eyes Vision in?
2Eyes Vision's product category is Ophthalmic Visual Simulation Devices. Its primary akta.pro industry code is HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics), with a secondary code of HLAKAKAN, Ocular Imaging & Diagnostic Testing Centers. Its NAICS code is 339115 and its SIC code is 3845.